Search

Your search keyword '"Song, Yu-Qin"' showing total 146 results
Start Over Author "Song, Yu-Qin"
146 results on '"Song, Yu-Qin"'

1. Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China

Author

Wang, Wei, Zhang, Wei, Su, Li-ping, Liu, Li-hong, Gao, Yu-huan, Wang, Quan-shun, Su, Hang, Song, Yu-qin, Zhang, Hui-lai, Shen, Jing, Jing, Hong-mei, Wang, Shu-ye, Cen, Xi-nan, Liu, Hui, Liu, Ai-chun, Li, Zeng-jun, Luo, Jian-min, He, Jian-xia, Wang, Jing-wen, O’Connor, O. A., and Zhou, Dao-bin

Published
2024
Full Text
View/download PDF

3. Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

Author

Li, Jia-Ying, Hou, Xiao-Rong, Chen, Si-Ye, Liu, Xin, Zhong, Qiu-Zi, Qian, Li-Ting, Qiao, Xue-Ying, Wang, Hua, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Zhang, Hui-Lai, Zhang, Xi-Mei, Su, Hang, Song, Yu-Qin, Zhu, Jun, Zhang, Yu-Jing, Huang, Hui-Qiang, Wang, Ying, He, Xia, Zhang, Li-Ling, Qu, Bao-Lin, Yang, Yong, Hu, Chen, Deng, Min, Wang, Shu-Lian, Qi, Shu-Nan, and Li, Ye-Xiong

Published
2023
Full Text
View/download PDF

4. Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Author

Deng, Li-Juan, Zhou, Ke-Shu, Liu, Li-Hong, Zhang, Ming-Zhi, Li, Zhi-Ming, Ji, Chun-Yan, Xu, Wei, Liu, Ting, Xu, Bing, Wang, Xin, Gao, Su-Jun, Zhang, Hui-Lai, Hu, Yu, Li, Yan, Cheng, Ying, Yang, Hai-Yan, Cao, Jun-Ning, Zhu, Zun-Min, Hu, Jian-Da, Zhang, Wei, Jing, Hong-Mei, Ding, Kai-Yang, Zhang, Xiang-Yang, Zhao, Ren-Bin, Zhang, Bin, Tian, Ya-Min, Song, Yong-Ping, Song, Yu-Qin, and Zhu, Jun

Published
2023
Full Text
View/download PDF

6. Multifractal analysis of weighted networks by a modified sandbox algorithm

Author

Song, Yu-Qin, Liu, Jin-Long, Yu, Zu-Guo, and Li, Bao-Gen

Subjects
Physics - Physics and Society
Abstract

Complex networks have attracted growing attention in many fields. As a generalization of fractal analysis, multifractal analysis (MFA) is a useful way to systematically describe the spatial heterogeneity of both theoretical and experimental fractal patterns. Some algorithms for MFA of unweighted complex networks have been proposed in the past a few years, including the sandbox (SB) algorithm recently employed by our group. In this paper, a modified SB algorithm (we call it SBw algorithm) is proposed for MFA of weighted networks.First, we use the SBw algorithm to study the multifractal property of two families of weighted fractal networks (WFNs): "Sierpinski" WFNs and "Cantor dust" WFNs. We also discuss how the fractal dimension and generalized fractal dimensions change with the edge-weights of the WFN. From the comparison between the theoretical and numerical fractal dimensions of these networks, we can find that the proposed SBw algorithm is efficient and feasible for MFA of weighted networks. Then, we apply the SBw algorithm to study multifractal properties of some real weighted networks ---collaboration networks. It is found that the multifractality exists in these weighted networks, and is affected by their edge-weights., Comment: 15 pages, 6 figures. Accepted for publication by Scientific Reports

Published
2015
Full Text
View/download PDF

8. Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Author

Yang, Yong, Wang, Ying, Liu, Xin, He, Xia, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Su, Hang, Song, Yu-Qin, Zhu, Jun, Zhang, Yu-Jing, Huang, Hui-Qiang, Hu, Chen, Qi, Shu-Nan, and Li, Ye-Xiong

Published
2021
Full Text
View/download PDF

9. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Author

Chen, Si-Ye, Yang, Yong, Qi, Shu-Nan, Wang, Ying, Hu, Chen, He, Xia, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Lan, Sheng-Min, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Yuan, Zhi-Yong, Yahalom, Joachim, Tsang, Richard, Song, Yu-Qin, Zhu, Jun, Su, Hang, and Li, Ye-Xiong

Published
2021
Full Text
View/download PDF

10. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Author

Qi, Shu-Nan, Yang, Yong, Song, Yu-Qin, Wang, Ying, He, Xia, Hu, Chen, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Huang, Hui-Qiang, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Yuan, Zhi-Yong, Su, Hang, Zhu, Jun, and Li, Ye-Xiong

Published
2020
Full Text
View/download PDF

11. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol

Author

Li, Jia-Ying, primary, Qi, Shu-Nan, additional, Hu, Chen, additional, Liu, Xin, additional, Yang, Yong, additional, Wu, Tao, additional, Zheng, Rong, additional, Feng, Xiao-Li, additional, Ni, Xiao-Guang, additional, Jin, Feng-Yan, additional, Song, Yu-Qin, additional, Liu, Wei-Ping, additional, Zhou, Sheng-Yu, additional, and Li, Ye-Xiong, additional

Published
2023
Full Text
View/download PDF

12. Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Author

Liu, Wei Ping, primary, Jiang, Bo, additional, Shuang, Yue Rong, additional, Zhao, Xing, additional, Zhong, Xuan Fan, additional, Tan, Ying, additional, Yu, Guo Jian, additional, Xue, Sheng Jie, additional, Shen, Wu Zhong, additional, Tu, Gui Yun, additional, Yang, Zheng, additional, Chen, Han Yang, additional, Xu, Jason, additional, Liu, Shui, additional, Yan, Xiao Qiang Qiang, additional, Zhu, Jun, additional, and Song, Yu Qin, additional

Published
2023
Full Text
View/download PDF

13. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma

Author

Song, Yu-Qin, primary, Zhang, Hui-Lai, additional, Huang, Hui-Qiang, additional, Zhang, Qing-Yuan, additional, Jing, Hong-Mei, additional, Wang, Chao, additional, Wu, Chun, additional, Li, Dong-Hang, additional, Dai, Yu, additional, Humphrey, Kathryn, additional, and Zhu, Jun, additional

Published
2023
Full Text
View/download PDF

14. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study

Author

Wei, Yu-Ce, primary, Liu, Wei-Xin, additional, Qi, Fei, additional, Zhang, Chang-Gong, additional, Zheng, Bao-Min, additional, Xie, Yan, additional, Chen, Bo, additional, Zhang, Di, additional, Liu, Wei-Ping, additional, Fang, Hui, additional, Chai, Yue, additional, Qi, Shu-Nan, additional, Li, Ye-Xiong, additional, Wang, Wei-Hu, additional, Song, Yu-Qin, additional, Zhu, Jun, additional, and Dong, Mei, additional

Published
2023
Full Text
View/download PDF

16. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.

Author

Li, Jia-Ying, Qi, Shu-Nan, Hu, Chen, Liu, Xin, Yang, Yong, Wu, Tao, Zheng, Rong, Feng, Xiao-Li, Ni, Xiao-Guang, Jin, Feng-Yan, Song, Yu-Qin, Liu, Wei-Ping, Zhou, Sheng-Yu, and Li, Ye-Xiong

Abstract

Low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type has a favorable outcome with radiation therapy alone, and the addition of chemotherapy shows no survival benefit. Nonetheless, a proportion of patients will relapse or progress, with a dismal outcome, highlighting the need for a novel therapeutic strategy. Promising preliminary findings indicate the efficacy of PD-1/PD-L1 inhibitors in extranodal natural killer/T-cell lymphoma, nasal type, with good toxicity profiles. Here we describe the design of a phase II study (CLCG-NKT-2101), which is evaluating the safety and efficacy of adding anti-PD-1 antibody to the current radiation therapy regimen in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type patients. Tislelizumab will be added in an inductive and concurrent way to radiation therapy. The primary end point will be the complete response rate after induction immunotherapy. Clinical trial registration:ClinicalTrials.gov (NCT05149170) [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Intensive therapy can improve long‐term survival in newly diagnosed, advanced‐stage extranodal NK/T‐cell lymphoma: A multi‐institutional, real‐world study

Author

Wei, Yu‐Ce, primary, Qi, Fei, additional, Zheng, Bao‐Min, additional, Zhang, Chang‐Gong, additional, Xie, Yan, additional, Chen, Bo, additional, Liu, Wei‐Xin, additional, Liu, Wei‐Ping, additional, Fang, Hui, additional, Qi, Shu‐Nan, additional, Zhang, Di, additional, Chai, Yue, additional, Li, Ye‐Xiong, additional, Wang, Wei‐Hu, additional, Song, Yu‐Qin, additional, Zhu, Jun, additional, and Dong, Mei, additional

Published
2023
Full Text
View/download PDF

18. Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Author

Yang, Yong, Wang, Ying, Liu, Xin, He, Xia, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Su, Hang, Song, Yu-Qin, Zhu, Jun, Zhang, Yu-Jing, Huang, Hui-Qiang, Hu, Chen, Qi, Shu-Nan, and Li, Ye-Xiong

Published
2021
Full Text
View/download PDF

19. Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database

Author

Liu, Xin, primary, Zhang, Li-Ling, additional, Qu, Bao-Lin, additional, Zhong, Qiu-Zi, additional, Qian, Li-Ting, additional, Yang, Yong, additional, Hou, Xiao-Rong, additional, Qiao, Xue-Ying, additional, Wang, Hua, additional, Zhu, Yuan, additional, Cao, Jian-Zhong, additional, Wu, Jun-Xin, additional, Wu, Tao, additional, Zhu, Su-Yu, additional, Shi, Mei, additional, Zhang, Hui-Lai, additional, Zhang, Xi-Mei, additional, Su, Hang, additional, Song, Yu-Qin, additional, Zhu, Jun, additional, Zhang, Yu-Jing, additional, Huang, Hui-Qiang, additional, Wang, Ying, additional, Chen, Fan, additional, Yin, Lin, additional, He, Xia, additional, Cai, Shang, additional, Li, Ye-Xiong, additional, and Qi, Shu-Nan, additional

Published
2023
Full Text
View/download PDF

20. Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T‐cell lymphoma

Author

Liu, Jia‐Xin, primary, Liu, Xin, additional, Yang, Yong, additional, Liu, Wei‐Ping, additional, Wang, Ying, additional, He, Xia, additional, Zhang, Li‐Ling, additional, Qu, Bao‐Lin, additional, Qian, Li‐Ting, additional, Hou, Xiao‐Rong, additional, Qiao, Xue‐Ying, additional, Wang, Hua, additional, Li, Gao‐Feng, additional, Zhu, Yuan, additional, Cao, Jian‐Zhong, additional, Wu, Jun‐Xin, additional, Wu, Tao, additional, Zhu, Su‐Yu, additional, Shi, Mei, additional, Zhang, Hui‐Lai, additional, Su, Hang, additional, Zhang, Yu‐Jing, additional, Zhu, Jun, additional, Qi, Shu‐Nan, additional, Li, Ye‐Xiong, additional, and Song, Yu‐Qin, additional

Published
2023
Full Text
View/download PDF

23. Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database

Author

Zheng, Xuan, primary, Qu, Bao‐Lin, additional, Liu, Xin, additional, Zhong, Qiu‐Zi, additional, Qian, Li‐Ting, additional, Yang, Yong, additional, Hou, Xiao‐Rong, additional, Qiao, Xue‐Ying, additional, Wang, Hua, additional, Zhu, Yuan, additional, Cao, Jian‐Zhong, additional, Wu, Jun‐Xin, additional, Wu, Tao, additional, Zhu, Su‐Yu, additional, Shi, Mei, additional, Zhang, Hui‐Lai, additional, Zhang, Xi‐Mei, additional, Su, Hang, additional, Song, Yu‐Qin, additional, Zhu, Jun, additional, Zhang, Yu‐Jing, additional, Huang, Hui‐Qiang, additional, Wang, Ying, additional, Chen, Fan, additional, Yin, Lin, additional, He, Xia, additional, Zhang, Li‐Ling, additional, Li, Ye‐Xiong, additional, and Qi, Shu‐Nan, additional

Published
2022
Full Text
View/download PDF

24. Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Author

Song, Yu-Qin, primary, Zhang, Hui-Lai, additional, Huang, Hui-Qiang, additional, Zhang, Qing-Yuan, additional, Jing, Hong-Mei, additional, Wang, Chao, additional, Wu, Chun, additional, Li, Dong-Hang, additional, Dai, Yu, additional, Humphrey, Kathryn, additional, and Zhu, Jun, additional

Published
2022
Full Text
View/download PDF

25. Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial

Author

Zhu, Jun, primary, Hong, Xiaonan, additional, Song, Yu Qin, additional, Hodkinson, Brendan, additional, Balasubramanian, Sriram, additional, Wang, Songbai, additional, Zhang, Qingyuan, additional, Shi, Yuankai, additional, Huang, Huiqiang, additional, Zhang, Huilai, additional, Zhu, Yan, additional, Shreeve, Stephen Martin, additional, Sun, Steven, additional, Wang, Ze, additional, Wang, Xiaocan, additional, Fan, Yue, additional, Wilson, Wyndham, additional, and Vermeulen, Jessica, additional

Published
2022
Full Text
View/download PDF

27. Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database.

Author

Zheng, Xuan, Qu, Bao‐Lin, Liu, Xin, Zhong, Qiu‐Zi, Qian, Li‐Ting, Yang, Yong, Hou, Xiao‐Rong, Qiao, Xue‐Ying, Wang, Hua, Zhu, Yuan, Cao, Jian‐Zhong, Wu, Jun‐Xin, Wu, Tao, Zhu, Su‐Yu, Shi, Mei, Zhang, Hui‐Lai, Zhang, Xi‐Mei, Su, Hang, Song, Yu‐Qin, and Zhu, Jun

Published
2023
Full Text
View/download PDF

32. Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy

Author

Wang, Chen-yu, primary, Sheng, Chang-cheng, additional, Ma, Guang-li, additional, Xu, Da, additional, Liu, Xiao-qin, additional, Wang, Yu-ya, additional, Zhang, Li, additional, Cui, Chuan-liang, additional, Xu, Bing-he, additional, Song, Yu-qin, additional, Zhu, Jun, additional, and Jiao, Zheng, additional

Published
2020
Full Text
View/download PDF

33. Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Author

Yang, Yong, primary, Wang, Ying, additional, Liu, Xin, additional, He, Xia, additional, Zhang, Li-Ling, additional, Wu, Gang, additional, Qu, Bao-Lin, additional, Qian, Li-Ting, additional, Hou, Xiao-Rong, additional, Zhang, Fu-Quan, additional, Qiao, Xue-Ying, additional, Wang, Hua, additional, Li, Gao-Feng, additional, Zhu, Yuan, additional, Cao, Jian-Zhong, additional, Wu, Jun-Xin, additional, Wu, Tao, additional, Zhu, Su-Yu, additional, Shi, Mei, additional, Xu, Li-Ming, additional, Su, Hang, additional, Song, Yu-Qin, additional, Zhu, Jun, additional, Zhang, Yu-Jing, additional, Huang, Hui-Qiang, additional, Hu, Chen, additional, Qi, Shu-Nan, additional, and Li, Ye-Xiong, additional

Published
2020
Full Text
View/download PDF

34. Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Author

Qi, Shu‐Nan, primary, Yang, Yong, additional, Zhang, Yu‐Jing, additional, Huang, Hui‐Qiang, additional, Wang, Ying, additional, He, Xia, additional, Zhang, Li‐Ling, additional, Wu, Gang, additional, Qu, Bao‐Lin, additional, Qian, Li‐Ting, additional, Hou, Xiao‐Rong, additional, Zhang, Fu‐Quan, additional, Qiao, Xue‐Ying, additional, Wang, Hua, additional, Li, Gao‐Feng, additional, Zhu, Yuan, additional, Cao, Jian‐Zhong, additional, Wu, Jun‐Xin, additional, Wu, Tao, additional, Zhu, Su‐Yu, additional, Shi, Mei, additional, Xu, Li‐Ming, additional, Yuan, Zhi‐Yong, additional, Su, Hang, additional, Song, Yu‐Qin, additional, Zhu, Jun, additional, Hu, Chen, additional, and Li, Ye‐Xiong, additional

Published
2020
Full Text
View/download PDF

35. Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy

Author

Wang, Chen-yu, primary, Sheng, Chang-cheng, additional, Ma, Guang-li, additional, Xu, Da, additional, Liu, Xiao-qin, additional, Wang, Yu-ya, additional, Zhang, Li, additional, Cui, Chuan-liang, additional, Xu, Bing-he, additional, Song, Yu-qin, additional, Zhu, Jun, additional, and Jiao, Zheng, additional

Published
2020
Full Text
View/download PDF

36. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Author

Chen, Si-Ye, primary, Yang, Yong, additional, Qi, Shu-Nan, additional, Wang, Ying, additional, Hu, Chen, additional, He, Xia, additional, Zhang, Li-Ling, additional, Wu, Gang, additional, Qu, Bao-Lin, additional, Qian, Li-Ting, additional, Hou, Xiao-Rong, additional, Zhang, Fu-Quan, additional, Qiao, Xue-Ying, additional, Wang, Hua, additional, Li, Gao-Feng, additional, Zhang, Yu-Jing, additional, Zhu, Yuan, additional, Cao, Jian-Zhong, additional, Lan, Sheng-Min, additional, Wu, Jun-Xin, additional, Wu, Tao, additional, Zhu, Su-Yu, additional, Shi, Mei, additional, Xu, Li-Ming, additional, Yuan, Zhi-Yong, additional, Yahalom, Joachim, additional, Tsang, Richard, additional, Song, Yu-Qin, additional, Zhu, Jun, additional, Su, Hang, additional, and Li, Ye-Xiong, additional

Published
2020
Full Text
View/download PDF

38. Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China

Author

Shi, Yun-Fei, Li, Xiang-Hong, Song, Yu-Qin, Song, Wei-Wei, and Lai, Yu-Mei

Subjects
Adult, Aged, 80 and over, Male, China, Adolescent, Lymphoma, Biopsy, Needle, Ki-1 Antigen, Reproducibility of Results, Bone Marrow Examination, Middle Aged, Antigens, CD20, Flow Cytometry, Prognosis, Immunohistochemistry, Young Adult, immune system diseases, Predictive Value of Tests, hemic and lymphatic diseases, Biomarkers, Tumor, Humans, Original Article, Female, Bone Marrow Neoplasms, Aged
Abstract

Objectives: This study aimed to evaluate key features of bone marrow trephine biopsy (BMT) involvement of lymphoma in Northern China. Methods: 950 cases were assessed for the occurrence of bone marrow involvement and architectural features including volume percentage, involvement pattern (diffuse, nodular, focal, para trabecular, or interstitial), and presence/absence of background changes (granuloma, stromal fibrosis or necrosis). Correlations with bone marrow aspirate (BMA) and flow cytometry (FCM) findings were made in a subset of paired cases (359 BMA and 364 FCM). Results: 153 (16.1%) cases involved BMT. The most frequent type was mantle cell lymphoma (28/153, 18.3%). Architectural features were similar to previous studies except that diffuse large B-cell lymphoma (DLBCL) preferred focal pattern (16/22 cases, 72.7%) most of all. BMA and BMT agreed in 84.1% of cases (302 of 359: 277 both negative, 25 both positive), while FCM and BMT agreed in 80.8% of cases (294 of 364: 242 both negative, 52 both positive). Both varied widely among different subgroups. Conclusions: Occurrence of BMT involvement by lymphoma in Northern China is relatively low. The volume percentage, distribution patterns and background changes may be useful pointers towards a particular lymphoma type in Chinese. FCM is more sensitive and reliable than BMA in China.

Published
2015

41. 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Author

Chang, Lung-Ji, primary, Dong, Lujia, additional, Zhu, Jun, additional, Ying, Zhitao, additional, Kuo, Hao-Hsian, additional, Liu, Yuchen, additional, Song, Yu-Qin, additional, Wang, Xiao-Pei, additional, Jia, Yong-Qian, additional, Niu, Ting, additional, Liu, Ting, additional, Pan, Ling, additional, Liu, Zhuo-Gang, additional, Li, Tong, additional, Li, Ying-Chun, additional, Yao, Kun, additional, Ke, Xiaoyan, additional, Jing, Hongmei, additional, and Bao, Fang, additional

Published
2015
Full Text
View/download PDF

42. Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma.

Author

Liu, Wei Ping, Wang, Xiao Pei, Zheng, Wen, Xie, Yan, Tu, Mei Feng, Lin, Ning Jing, Ping, Ling Yan, Ying, Zhi Tao, Zhang, Chen, Deng, Li Juan, Ding, Ning, Wang, Xiao Gan, Song, Yu Qin, and Zhu, Jun

Subjects
LYMPHOMAS, LYMPHOMA treatment, PULMONARY fibrosis, THERAPEUTIC use of glucocorticoids, HEALTH outcome assessment, PATIENTS, ANTINEOPLASTIC agents, LYMPHOMA diagnosis, INTERSTITIAL lung diseases, PROGNOSIS, RESEARCH funding, SURVIVAL analysis (Biometry), TREATMENT effectiveness, DISEASE incidence, RETROSPECTIVE studies, DISEASE complications, DIAGNOSIS
Abstract

Interstitial pneumonia (IP) is a lethal complication in lymphoma patients undergoing chemotherapy. A total of 2212 consecutive patients diagnosed with lymphoma between 2009 and 2014 were enrolled in the present study. IP was defined as diffuse pulmonary interstitial infiltrate found on computed tomography scans. IP was observed in 106 patients. Of these, 23 patients were excluded from the study. Finally, 83 patients with IP were included in this study. The incidence of IP was 3.9% (7/287) in Hodgkin lymphoma and 2.4% (76/1925) in non-Hodgkin lymphoma (P = 0.210). The median number of chemotherapy cycles before IP was 3. The median time from the cessation of chemotherapy to IP was 17 days. Eighty-two (98.8%) patients recovered after the treatment with glucocorticoids. Sixty-six (79.5%) patients had a delay in chemotherapy, and 14 (16.9%) patients had premature termination of chemotherapy. Sixty-nine patients were re-treated with chemotherapy after remission from IP, of which 22 (31.9%) experienced IP recurrence. The incidence of IP recurrence was significantly higher in patients re-treated with a similar regimen than in those re-treated with an alternative regimen (65.4 vs. 11.6%, P < 0.001). In a multivariate Cox regression analysis, B symptoms and a history of drug allergies were identified as risk factors for IP. In conclusion, IP is a life-threatening complication in lymphoma patients. Glucocorticoid therapy with continuous monitoring of chest radiographic changes may be a favourable strategy for treating IP. However, IP may recur, especially in patients re-treated with a similar chemotherapy regimen. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

43. 415. First-In-Patient Proof of Safety and Efficacy of a 4th Generation Chimeric Antigen Receptor-Modified T Cells for the Treatment of Relapsed or Refractory CD30 Positive Lymphomas

Author

Ying, Zhi-Tao, primary, Chang, Lung-Ji, additional, Kuo, Hao-Hsiang, additional, Liu, Yu-Chen, additional, Song, Yu-Qin, additional, Wang, Xiao-Pei, additional, Liu, Wei-Ping, additional, Zheng, Wen, additional, Xie, Yan, additional, Lin, Ning-Jing, additional, Tu, Mei-Feng, additional, Ping, Ling-Yang, additional, Zhang, Chen, additional, Huang, Hui-Ying, additional, and Zhu, Jun, additional

Published
2015
Full Text
View/download PDF

44. Robust fault diagnosis method of flight control system based on disturbance decoupling assignment

Author

Zhang Weiguo and Song Yu-qin

Subjects
Engineering, business.industry, Control engineering, Hardware_PERFORMANCEANDRELIABILITY, Residual, Automation, Transfer function, Fault detection and isolation, Robustness (computer science), Control theory, Control system, business, human activities, Decoupling (electronics)
Abstract

The observer of fault detection and diagnosis is designed based on disturbance decoupling assignment aimed at flight control system having unknown input disturbances. It makes residual in quadrature with disturbances distributed direction through left eigenstructure assignment to observer. The transfer function is zero between fault detection residual r and unknown input disturbance d. So it makes residual decoupling and robust with disturbance. The fault diagnosis and isolation algorithm is not influenced by the system uncertain disturbances. The reliability and precision of fault diagnosis are improved. Meanwhile it can identify faults shape online through residual estimating faults. The simulation results verify method validity.

Published
2010

45. Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group

Author

Kim, Seok Jin, primary, Jung, Hyun Ae, additional, Chuang, Shih-Sung, additional, Hong, Huangming, additional, Guo, Cheng-Cheng, additional, Cao, Junning, additional, Hong, Xiao-Nan, additional, Suzuki, Ritsuro, additional, Kang, Hye Jin, additional, Won, Jong Ho, additional, Chng, Wee-Joo, additional, Kwong, Yok-Lam, additional, Suh, Cheolwon, additional, Song, Yu-Qin, additional, Zhu, Jun, additional, Tay, Kevin, additional, Lim, Soon Thye, additional, Suzumiya, Junji, additional, Lin, Tong-Yu, additional, and Kim, Won Seog, additional

Published
2013
Full Text
View/download PDF

46. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group

Author

Kim, Seok Jin, primary, Hsu, Chiun, additional, Song, Yu-Qin, additional, Tay, Kevin, additional, Hong, Xiao-Nan, additional, Cao, Junning, additional, Kim, Jin Seok, additional, Eom, Hyeon Seok, additional, Lee, Joon Hyeok, additional, Zhu, Jun, additional, Chang, Kian-Meng, additional, Reksodiputro, Arry Harryanto, additional, Tan, Daryl, additional, Goh, Yeow Tee, additional, Lee, Jejung, additional, Intragumtornchai, Tanin, additional, Chng, Wee-Joo, additional, Cheng, Ann-Lii, additional, Lim, Soon Thye, additional, Suh, Cheolwon, additional, Kwong, Yok-Lam, additional, and Kim, Won Seog, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results